Effectiveness of Pfizer vaccination at a measly 12% – instead of the specified 95%

BioNTech/Pfizer’s experimental vaccine is 95% effective, the manufacturer said. That claim doesn’t appear to be true, according to an FDA backgrounder for the BioNTech/Pfizer COVID-19 Vaccine Advisory Committee (VRBPAC) meeting. If the effectiveness of the vaccine is calculated using the figures in this report, it is only 12%. In the first quarter of 2022 alone, Pfizer was able to make a profit of around $7.9 billion, mostly from the mRNA vaccine.

Pfizer is proud of a 61% increase in sales over the previous year

“I am very proud of our development,” Pfizer CEO Albert Bourla said in a stock market report. The company increased its sales by 61% compared to the previous year. Without the vaccine and the drug Paxlovid, the increase would have been only 2% turned out rather skinny.

Handling? CT values ​​not reported

The document (page 13) states that Pfizer has a “central laboratory” used to Covid-19 cases using a PCR test confirm, according to a report on Substack. The used one has CT value (Cycle Threshold), which indicates how many times the sample has been doubled great influence on the result of the test. A study has shown that at 35 cycle PCR assays or more the Accuracy drops to 3%. It means that up to 97% of positive results may be false positives. The document does not specify which CT value was used in this central laboratory.

Pfizer’s Vaccine’s claimed 95% effectiveness rate comes from PCR test resultscreated by this central laboratory. the Pfizer’s pivotal study was not “blinded”which means that the researchers who conducted the study knew which subjects were vaccinated and which only a placebo had obtained. If a study is not blinded, it can lead to serious distortion of the data. Since CT values ​​are not given, it is also possible that CT values ​​in unvaccinated Participants (placebo) suspected of having COVID-19, possibly started became. It would then be with a high probability leads to positive Covid results. Both vaccinated participants, the CT value used could have been much lower, making a negative result more likely.

Emergency admission due to insufficient data?

Page 24 of the document contains the data on the basis of which supposedly 95 percent vaccine effectiveness has been calculated. This results from the 8 confirmed cases of Covid in the vaccinated group against 162 cases in the placebo group. Based on this data, in the United States by the FDA Emergency Use Authorization and for Europe through EMA Conditional Approval for the Pfizer-BioNTech vaccine.

Only 12% efficiency instead of the claimed 95%

On page 42 of this document, there is an important section that may refer to the real effectiveness of the vaccine closes:

“Of the total of 3410 suspected but unconfirmed cases of COVID-19 in the entire study population, 1594 occurred in the vaccinated group and 1816 in the placebo group. Suspected cases of COVID-19 within 7 days of vaccination has occurred were 409 in the vaccine group versus 287 in the placebo group“If you die Calculating the effectiveness of “vaccination” from these figures yields a shockingly low value of only 12%! Compared to the claimed effectiveness of 95%, as quoted by Pfizer, a truly miserable value! Considering that the vaccine serious side effects can trigger how BioNTech was recently admitted to the United States Securities and Exchange Commission (weekly view reported), then there is actually nothing to say for this “vaccine”.

The Pfizer/BioNTech report for the US Food and Drug Administration:

Leave a Comment